EP3227454
Aðferð til að stjórna fjölsykruinnihaldi í glýkóprótíni
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
1.12.2015EP published:
29.1.2020EP application number:
15816598.5
EP translation filed:
7.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
30.11.2035Expiry date:
30.11.2025
Title:
PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
Timeline
Today
1.12.2015EP application
29.1.2020EP Publication
7.4.2020Translation submitted
15.5.2020Registration published
30.11.2025Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
LEISKE, Daniel R.Address:
Issaquah, Washington 98027, US
Name:
TRENTALANGE, Michael T.Address:
Seattle, Washington 98112, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462085759 PDate:
1.12.2014Country:
US
Classification
Categories:
C12P 21/00, C12P 21/02, C07K 16/00, C07K 14/00, C07K 16/24, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 6.11.2020
Expires: 30.11.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.11.2021
Expires: 30.11.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 22.11.2022
Expires: 30.11.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.11.2023
Expires: 30.11.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 21.11.2024
Expires: 30.11.2025
Payer: Árnason Faktor ehf.